Suresh Vazirani

Start-up Year: 1979
Number of Employees: 850
Turnover in Previous Year: Rs. 227 crore (revenue in last fiscal year)
Principal/Channel Partners: Sysmex Corporation, Japan; MEDICA, USA; Diesse, Italy; WAKO, Japan; Fujirebio Diagnostics, Inc.
Current Export Markets: Over 55 countries including China, Indonesia, S.Korea, Vietnam, Egypt, Tanzania, Kenya, Turkey, France, Italy, Spain, Poland, Russia, Venezuela, Columbia, Dominican Republic, Equador
Quality Systems/Certifications: ISO 9001, ISO 13485

Company Profile

Transasia Bio-Medicals Ltd. is the leader in the clinical diagnostics segment of the Indian healthcare sector, providing total solutions for clinical diagnosis. With an enviable 30 year track record in the industry, the company is the largest Indian manufacturer and exporter of diagnostic instruments and reagents. The company has become a name to reckon with, in India and about 55 countries across the world.

Service support for Transasia equipments and the infrastructure that the company has built to support this has helped to set benchmarks for the industry in terms of service expectations.

Transasia today has the largest sales and installation base with over 15000 installations all over the country supported by a network of 102 service engineers, 58 centres and 14 zonal offices at metros and major cities backed by a strong force of trained engineers and customer training personnel.

Transasia has a 100% subsidiary in Germany, Erba Diagnostics Mannheim GmbH. With its team of experienced marketing and service professionals and an extensive distribution network spread over 55 countries worldwide, Erba Diagnostics Mannheim is playing a stellar role in bringing world-class products within reach of laboratories across the globe. Today, its products enjoy a strong global presence and are exported to Italy, Germany, France, Australia, China, Turkey, USA., Latin America, Africa, Russia, Middle East, SAARC and Asia.

Transasia is equipped to manufacture instruments, reagents and consumables conforming to IVD Directives. The company has manufacturing facilities at Daman, SEEPZ (Mumbai), Baddi (Himachal Pradesh) and Mannheim (Germany).

PRODUCT DETAILS/SOLUTIONS

Transasia Bio-Medicals Ltd offers ‘Total Solutions for Clinical Diagnosis’ whether it is biochemistry, haematology, immunology, critical care, coagulation, urine analysis, liquid handling systems or blood transfusion medicine. Transasia has a complete suit of semi auto to fully automated instruments which are indigenously manufactured at its state of the art manufacturing units or through its alliances with global leaders in the respective segments.

Acquired Pliva Lachema Diagnostika, a 42 year old company located in Czech Republic, engaged in the development, production and marketing of in-vitro diagnostics products consisting of a range of products for urine analysis, biochemistry and microbiology.

• Rated as India’s largest In-vitro Diagnostics Company (2006) by McEvoy & Farmer, USA (International Experts on IVD Markets). 
• “Clearstate” in their survey (2007) have revealed Transasia’s market leadership over international players specifically in Clinical Chemistry and Haematology. It also mentions Transasia’s Erba Chem Series as the most placed Clinical Chemistry (CC) analysers in all types of facilities. 

PRODUCT DETAILS/SOLUTIONS

Transasia plans to expand its existing product range and venture into new areas like microbiology and veterinary science. It also wishes to contribute to the analytical research field in India. Transasia plans to expand its exports to over 100 countries by 2012. It also plans to have a subsidiary company in the USA, which can give it a significant market share there.